Posted today in New Drug Approvals

FDA Approves Besponsa (inotuzumab ozogamicin) for Relapsed or Refractory Acute Lymphoblastic Leukemia

The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). “For adult patients with B-cell ALL whose cancer has not responded to initial treatment or has returned after treatment, life expectancy is typically low,”...

Posted today in Medical

Could Urban Lighting Raise Breast Cancer Risk for Some Women?

New research reveals an unexpected potential risk factor for breast cancer: city lights. The Harvard Medical School study found an association between living in areas with high amounts of ambient nighttime light and slightly increased odds for breast cancer in younger women who smoke. "In our modern industrialized society, artificial lighting is nearly...

Posted today in Medical

Voters in Counties With Worse Life Expectancy Turned to Trump in Election

Offering another take on the forces behind the last presidential election, a new study reveals a link between living in an area where life expectancy is lower and voting for Donald Trump. Researchers have long associated lower life expectancy rates with poverty, lack of health insurance and unhealthy lifestyles. The latest finding stems from an analysis...

Posted 2 days ago in Clinical Trials

ARCA Biopharma Announces Completion of Enrolment for GENETIC-AF Phase 2B Clinical Trial Evaluating Gencaro (bucindolol hydrochloride)

ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced the completion of enrolment for GENETIC-AF, a Phase 2B, double-blind, superiority clinical trial evaluating Gencaro (bucindolol hydrochloride) as a potential...

Posted today in Medical

Health Tip: Food Prep 101

-- Nothing chases away the college-cafeteria blues faster than preparing your own food. But make sure you handle it properly to avoid getting you and your roomies sick. The foodsafety.gov website suggests: Wash your hands frequently with soap and hot water. Clean all surfaces thoroughly before putting food on them. Avoid using the same cutting board...

Posted today in Medical

Health Tip: Flu Season is Around the Corner

-- For many people basking in the warmth of summer, the flu season may seem like a distant memory. Truth is, the start of the next one is only a month or two away. The U.S. Veterans Administration reminds us about the possible symptoms of flu: Fever Shortness of breath Pain in the chest or abdomen Nausea and vomiting Trouble holding down food and liquids Weakness...

Posted today in Medical

Kidney Disease May Boost Odds of Infection

As kidney function declines, infection risk rises, a new study shows. Infections facing people with advanced kidney disease include lower respiratory tract disease, urinary tract infections and blood poisoning, researchers said. The findings were published Aug. 17 in the Clinical Journal of the American Society of Nephrology. "Given the fact that chronic...

Posted today in Medical

Zika May Not Last in Semen as Long as Thought

Zika virus might not remain in the semen of some infected men as long as previously thought, a small study suggests. The researchers said Zika may only be present in semen for about a month. Previous research had suggested that Zika virus can be found in semen for as long as 188 days after the onset of symptoms. The new study included 12 men in French...

Posted today in Medical

Get Ready, Safely, for the Great American Eclipse

One of the biggest celestial events of a lifetime -- a total solar eclipse -- is heading towards millions of Americans on Monday. But what's the safest way for your eyes to view it? The total eclipse -- the first in nearly a century to stretch across the continental U.S. -- will treat millions to a fleeting and unforgettable sight when the sun disappears...

Posted today in Medical

Health Highlights: Aug. 18, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: EpiPen Maker Settles Government Lawsuit for $465 Million The maker of EpiPen has agreed to pay the federal government $465 million to settle claims that it overbilled Medicaid for a decade. This is not the first settlement that Mylan Inc. has made...

Recently added consumer and prescribing information: Mavyret, Idhifa, Vosevi, Nerlynx, Tremfya, Bevyxxa, Rituxan Hycela, Baxdela, Imfinzi, Radicava

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]